FDAFebruary 20, 2019device
ARIES GBS Assay , REF 50-10021, UDI # 00840487100165
Official recall recorded by the U.S. Food & Drug Administration.
The hazard
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
What to do
FDA enforcement status: Ongoing
Brands named
luminex
UPCs
00840487100165
Recall history
Other federal recalls tied to the same brand — a factual pattern, straight from the source data.
- FDAVERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test2025-04-16
- FDANxTAG Respiratory Pathogen Panel, REF: I051C04472024-09-05
- FDANxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C04682024-09-05
- FDAVerigene Gram Positive Blood Culture (BC-GP) Nucleic Acid Test2024-06-20
- FDALuminex VERIGENE BC-GP Utility Tray (5-Pack Carrier), Gram-Positive Blood Culture Nucleic Acid Test, REF 20-011-018, a component of the Luminex VERIGENE BC-GP Utility Kit, REF 20-012-018, containing 20 tests.2023-11-07
- FDAVerigene Enteric Pathogens Nucleic Acid Test (EP), REF 30-002-0232023-06-05
- FDAVERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-0222023-06-05
- FDAARIES SARS-CoV-2 Assay, REF: 50-100472022-09-14
Own something like this?
AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.
Start free — 200 items, no card →